MiR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3

Zhengrong Li, Yi Cao, Zhigang Jie, Yi Liu, Yingliang Li, Junhe Li, Guoming Zhu, Zhengren Liu, Yi Tu, Gen Peng, Dong woo Lee, Sungsoo Park

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

The phosphatase of regenerating liver-3 (. PRL-. 3) gene is associated with metastasis in gastric cancer, and is believed to play a causative role by promoting tumor cell motility, invasion, and metastasis, but little is known of the mechanisms involved. We previously reported that . PRL-. 3 expression is significantly higher in the tissues of primary gastric carcinomas with peritoneal metastasis. In the present study, we found that two microRNAs (miRNAs), miR-495 and miR-551a, predicted to target . PRL-. 3, are downregulated in gastric carcinoma samples. The validation of this interaction between those two miRNAs and . PRL-. 3 was confirmed by western blotting and quantitative real-time PCR (qPCR) in GC cell lines transfected with miR-495 and miR-551a mimics. Furthermore, the migration and invasion of GC cells were significantly inhibited by transfection with miR-495 or -551a mimics, and the mRNA and protein levels of . PRL-. 3 were reduced in cells overexpressing miR-495 or -551a. Collectively, our findings suggest that miR-495 and miR-551a both act as tumor suppressors by targeting the . PRL-. 3 oncogene and inhibiting gastric cancer cell migration and invasion. The findings of this study contribute to current understanding of the functions of miRNA mimics in GC gene therapy.

Original languageEnglish
Pages (from-to)41-47
Number of pages7
JournalCancer Letters
Volume323
Issue number1
DOIs
Publication statusPublished - 2012 Oct 1

Fingerprint

MicroRNAs
Stomach Neoplasms
Neoplasm Metastasis
Cell Movement
Stomach
Carcinoma
Oncogenes
Phosphoric Monoester Hydrolases
Genetic Therapy
Transfection
Real-Time Polymerase Chain Reaction
Neoplasms
Down-Regulation
Western Blotting
Cell Line
Messenger RNA
Liver
Genes
Proteins

Keywords

  • Gastric carcinoma
  • MiR-495
  • MiR-551a
  • PRL-3

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

MiR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. / Li, Zhengrong; Cao, Yi; Jie, Zhigang; Liu, Yi; Li, Yingliang; Li, Junhe; Zhu, Guoming; Liu, Zhengren; Tu, Yi; Peng, Gen; Lee, Dong woo; Park, Sungsoo.

In: Cancer Letters, Vol. 323, No. 1, 01.10.2012, p. 41-47.

Research output: Contribution to journalArticle

Li, Zhengrong ; Cao, Yi ; Jie, Zhigang ; Liu, Yi ; Li, Yingliang ; Li, Junhe ; Zhu, Guoming ; Liu, Zhengren ; Tu, Yi ; Peng, Gen ; Lee, Dong woo ; Park, Sungsoo. / MiR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. In: Cancer Letters. 2012 ; Vol. 323, No. 1. pp. 41-47.
@article{a5b58e475ddb474d83862f74fe6d7094,
title = "MiR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3",
abstract = "The phosphatase of regenerating liver-3 (. PRL-. 3) gene is associated with metastasis in gastric cancer, and is believed to play a causative role by promoting tumor cell motility, invasion, and metastasis, but little is known of the mechanisms involved. We previously reported that . PRL-. 3 expression is significantly higher in the tissues of primary gastric carcinomas with peritoneal metastasis. In the present study, we found that two microRNAs (miRNAs), miR-495 and miR-551a, predicted to target . PRL-. 3, are downregulated in gastric carcinoma samples. The validation of this interaction between those two miRNAs and . PRL-. 3 was confirmed by western blotting and quantitative real-time PCR (qPCR) in GC cell lines transfected with miR-495 and miR-551a mimics. Furthermore, the migration and invasion of GC cells were significantly inhibited by transfection with miR-495 or -551a mimics, and the mRNA and protein levels of . PRL-. 3 were reduced in cells overexpressing miR-495 or -551a. Collectively, our findings suggest that miR-495 and miR-551a both act as tumor suppressors by targeting the . PRL-. 3 oncogene and inhibiting gastric cancer cell migration and invasion. The findings of this study contribute to current understanding of the functions of miRNA mimics in GC gene therapy.",
keywords = "Gastric carcinoma, MiR-495, MiR-551a, PRL-3",
author = "Zhengrong Li and Yi Cao and Zhigang Jie and Yi Liu and Yingliang Li and Junhe Li and Guoming Zhu and Zhengren Liu and Yi Tu and Gen Peng and Lee, {Dong woo} and Sungsoo Park",
year = "2012",
month = "10",
day = "1",
doi = "10.1016/j.canlet.2012.03.029",
language = "English",
volume = "323",
pages = "41--47",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - MiR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3

AU - Li, Zhengrong

AU - Cao, Yi

AU - Jie, Zhigang

AU - Liu, Yi

AU - Li, Yingliang

AU - Li, Junhe

AU - Zhu, Guoming

AU - Liu, Zhengren

AU - Tu, Yi

AU - Peng, Gen

AU - Lee, Dong woo

AU - Park, Sungsoo

PY - 2012/10/1

Y1 - 2012/10/1

N2 - The phosphatase of regenerating liver-3 (. PRL-. 3) gene is associated with metastasis in gastric cancer, and is believed to play a causative role by promoting tumor cell motility, invasion, and metastasis, but little is known of the mechanisms involved. We previously reported that . PRL-. 3 expression is significantly higher in the tissues of primary gastric carcinomas with peritoneal metastasis. In the present study, we found that two microRNAs (miRNAs), miR-495 and miR-551a, predicted to target . PRL-. 3, are downregulated in gastric carcinoma samples. The validation of this interaction between those two miRNAs and . PRL-. 3 was confirmed by western blotting and quantitative real-time PCR (qPCR) in GC cell lines transfected with miR-495 and miR-551a mimics. Furthermore, the migration and invasion of GC cells were significantly inhibited by transfection with miR-495 or -551a mimics, and the mRNA and protein levels of . PRL-. 3 were reduced in cells overexpressing miR-495 or -551a. Collectively, our findings suggest that miR-495 and miR-551a both act as tumor suppressors by targeting the . PRL-. 3 oncogene and inhibiting gastric cancer cell migration and invasion. The findings of this study contribute to current understanding of the functions of miRNA mimics in GC gene therapy.

AB - The phosphatase of regenerating liver-3 (. PRL-. 3) gene is associated with metastasis in gastric cancer, and is believed to play a causative role by promoting tumor cell motility, invasion, and metastasis, but little is known of the mechanisms involved. We previously reported that . PRL-. 3 expression is significantly higher in the tissues of primary gastric carcinomas with peritoneal metastasis. In the present study, we found that two microRNAs (miRNAs), miR-495 and miR-551a, predicted to target . PRL-. 3, are downregulated in gastric carcinoma samples. The validation of this interaction between those two miRNAs and . PRL-. 3 was confirmed by western blotting and quantitative real-time PCR (qPCR) in GC cell lines transfected with miR-495 and miR-551a mimics. Furthermore, the migration and invasion of GC cells were significantly inhibited by transfection with miR-495 or -551a mimics, and the mRNA and protein levels of . PRL-. 3 were reduced in cells overexpressing miR-495 or -551a. Collectively, our findings suggest that miR-495 and miR-551a both act as tumor suppressors by targeting the . PRL-. 3 oncogene and inhibiting gastric cancer cell migration and invasion. The findings of this study contribute to current understanding of the functions of miRNA mimics in GC gene therapy.

KW - Gastric carcinoma

KW - MiR-495

KW - MiR-551a

KW - PRL-3

UR - http://www.scopus.com/inward/record.url?scp=84861807243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861807243&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2012.03.029

DO - 10.1016/j.canlet.2012.03.029

M3 - Article

C2 - 22469786

AN - SCOPUS:84861807243

VL - 323

SP - 41

EP - 47

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -